8 October 2020 - The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to develop and produce a COVID-19 vaccine, while engaging in strategic international partnerships to support access for Australia and our region.
Under its COVID-19 Vaccine and Treatment Strategy, the Australian Government is investing $1.7 billion to pre-order 84.8 million doses of vaccine with leading Australian manufacturer CSL Limited (Seqirus) and UK-based AstraZeneca.